Search, personalize, or simply browse. Follow the world around you from gist and context to insights.
Who we are | Our Credo | Ways of using Lyrarc | FAQ | Send Feedback | First Letter From the Editor
Sign up. It's free and easy to use
Create an account
to personalize your feed of articles and topics.
During the early stages of the acquisition of Genentech questions were raised whether the bigger Swiss compay would end up stifling the research culture at Gennetech and reaearch scientists woul leave. As it turned out few have left and Roche head Severin Schwan has committed Roche to focussing on research as ahuge opportunity for pharmaceuticals as he sees drugmaking still "so crude," and the opportunities vast with advances in biotechnology, diagnostics, and genomics.
Economist 12/10/2009
Roche's Big Hurdle with Genentech
BusinessWeek 07/24/2008
We took a different way to help millions around the world build educated informed mindsets that affects and shapes their lives. For a future that is open, global and digital, with everyone having access to high quality information. We believe in the renewal of America, renewal of Europe, the renewal of India, the rest of Asia, Latin America and Africa. The renewal of our supply chains, health, education, infrastructure, as we rebuild our countries after the pandemic. Literacy and knowledge we believe cannot thrive and grow in a world of web bots, web crawlers, or AI. This requires human curiosity, human learning, and human imagination. We take as inspiration the saying- “One has to be free, and as broad as sky. One has to have a mind that is crystal clear, only then can truth shine in it.” Every contribution whether big or small is precious- in this crisis and ahead.
Support Lyrarc from as small as $1